It would also be important to examine expression of CCL2/CCR2 chemokine signaling proteins in a retrospective cohort of DCIS with outcome data, and prospective cohort of patient DCIS with follow-up studies on outcome. The gene discussed is CCL2; the disease is ductal breast carcinoma in situ.